Skip to content
OpenCapital
Get started

HealthStream HSTM Equity in earnings (losses) of equity method investees

Equity in earnings (losses) of equity method investees at other companies

Healthcare Services Group logo
Healthcare Services GroupHCSG
——
ResMed logo
ResMedRMD
——

Other financials

Income statement

See full
Revenue$81.2M+10.5%
Gross profit$49.2M+1.6%
Operating income$5.1M-4.9%
Net income$5.9M+28.9%
EPS (diluted)$0.15-7.6%

Balance sheet

See full
Cash & equivalents$48.7M-37.0%
Total debt$14.1M-15.5%
Total equity$352.0M-3.0%
Total assets$527.4M+0.6%

Cash flow

See full
Operating cash flow$27.1M+0.2%
CapEx$740.0K-29.9%
Free cash flow$26.4M+1.4%

Valuation

See full
Market cap$762.81M-7.5%
Enterprise value$728.16M-4.7%
P/E38.8×-3.3×
P/S2.5×-0.4×

Profitability

See full
Gross margin64.7%-1.7pp
Operating margin6.7%-0.6pp
Net margin6.3%-0.4pp
FCF margin19.2%-2.0pp

Returns & leverage

See full
Return on equity5.5%0.0pp
Debt / equity0×0.0×
Current ratio1×-0.4×

Where this comes from

Reported directly by HealthStream in its filing.

Tagged under the XBRL concept us-gaap:IncomeLossFromEquityMethodInvestments.

The official record: HealthStream’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthStream's equity in earnings (losses) of equity method investees.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthStream's equity in earnings (losses) of equity method investees?
HealthStream (HSTM) reported equity in earnings (losses) of equity method investees of -$40K in Q1 2026.
How has HealthStream's equity in earnings (losses) of equity method investees changed year-over-year?
HealthStream's equity in earnings (losses) of equity method investees increased by 44.4% year-over-year, from -$72K to -$40K.
What is the long-term trend for HealthStream's equity in earnings (losses) of equity method investees?
Over 4 years (2021 to 2025), HealthStream's equity in earnings (losses) of equity method investees has grown at a -19.9% compound annual growth rate (CAGR), from -$462K to -$190K.